Page 21 - Demo

www.psypharma.ru %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u2116 4/2024%u041c%u0438%u0440%u043e%u0448%u043d%u0438%u0447%u0435%u043d%u043a%u043e %u0418.%u0418., %u041a%u0443%u0437%u044c%u043c%u0438%u043d %u0418.%u0418., %u0418%u0432%u0430%u0449%u0435%u043d%u043a%u043e %u0414.%u0412. 21 %u0418%u0421%u0421%u041b%u0415%u0414%u041e%u0412%u0410%u041d%u0418%u042f %u041e%u0420%u0418%u0413%u0418%u041d%u0410%u041b%u042c%u041d%u042b%u0415 10. %u0412%u043e%u0440%u043e%u043d%u0438%u043d%u0430 %u0422.%u0410., %u041b%u0430%u0440%u0438%u043e%u043d%u043e%u0432 %u0412.%u0411., %u0413%u043e%u043b%u043e%u0432%u0435%u043d%u043a%u043e %u041d.%u042f., %u041d%u0435%u0440%u043e%u0431%u043a%u043e%u0432%u0430 %u041b.%u041d., %u0413%u0430%u0439%u0434%u0443%u043a%u043e%u0432 %u0418.%u041e. %u0420%u043e%u043b%u044c 3-%u043e%u043a%u0441%u0438%u043c%u0435%u0442%u0430%u0431%u043e%u043b%u0438%u0442%u0430 %u0444%u0435%u043d%u0430%u0437%u0435%u043f%u0430%u043c%u0430 %u0438 %u043b%u0435%u0432%u0430%u043d%u044b %u0432 %u0440%u0435%u0430%u043b%u0438%u0437%u0430%u0446%u0438%u0438 %u0438%u0445 %u043d%u0435%u0439%u0440%u043e%u0442%u0440%u043e%u043f%u043d%u043e%u0433%u043e %u0434%u0435%u0439%u0441%u0442%u0432%u0438%u044f // %u0424%u0430%u0440%u043c%u0430%u043a%u043e%u043a%u0438%u043d%u0435%u0442%u0438%u043a%u0430 %u0438 %u0444%u0430%u0440%u043c%u0430%u043a%u043e%u0434%u0438%u043d%u0430%u043c%u0438%u043a%u0430. %u2013 2014. %u2013 %u2116 1. %u2013 %u0421. 44%u201349.10. Voronina T.A., Larionov V.B., Golovenko N.Ja., Nerobkova L.N., Gajdukov I.O. Rol%u203a 3-oksimetabolita fenazepama i levany v realizacii ih nejrotropnogo dejstvija // Farmakokinetika i farmakodinamika. %u2013 2014. %u2013 %u2116 1. %u2013 S. 44%u201349.11. %u0413%u043e%u0440%u0434%u0435%u0435%u0432 %u0418.%u0413., %u041e%u043b%u0435%u043d%u0435%u0432%u0430 %u0415.%u0412., %u0413%u043b%u043e%u0431%u0435%u043d%u043a%u043e %u0410.%u0410., %u041a%u0430%u043f%u0430%u0448%u0438%u043d %u0410.%u0412., %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d. %u0424%u0430%u0440%u043c%u0430%u043a%u043e%u043a%u0438%u043d%u0435%u0442%u0438%u0447%u0435%u0441%u043a%u043e%u0435 %u0438%u0441%u0441%u043b%u0435%u0434%u043e%u0432%u0430%u043d%u0438%u0435 %u0431%u0438%u043e%u044d%u043a%u0432%u0438%u0432%u0430%u043b%u0435%u043d%u0442%u043d%u043e%u0441%u0442%u0438 %u043e%u0440%u043e%u0434%u0438%u0441%u043f%u0435%u0440%u0433%u0438%u0440%u0443%u0435%u043c%u044b%u0445 %u0442%u0430%u0431%u043b%u0435%u0442%u043e%u043a %u0444%u0435%u043d%u0430%u0437%u0435%u043f%u0430%u043c%u0430 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2020. %u2013 %u2116 2. %u2013 %u0421. 19%u201325. %u2013 https://doi.org/10.21265/PSYPH.2020.37.97.0011. Gordeev I.G., Oleneva E.V., Globenko A.A., Kapashin A.V., Mosolov S.N. Farmakokineticheskoe issledovanie biojekvivalentnosti orodispergiruemyh tabletok fenazepama // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2020. %u2013 %u2116 2. %u2013 S. 19%u201325. %u2013 https://doi.org/10.21265/PSYPH.2020.37.97.0012. Brunetti P., Giorgetti R., Tagliabracci A., Huestis M.A., Busard%u00f2 F.P. Designer benzodiazepines: A review of toxicology and public health risks // Pharmaceuticals (Basel). %u2013 2021. %u2013 Vol. 14 (6). %u2013 Art. 560. %u2013 https://doi.org/10.3390/ph1406056012. Brunetti P., Giorgetti R., Tagliabracci A., Huestis M.A., Busard%u00f2 F.P. Designer benzodiazepines: A review of toxicology and public health risks // Pharmaceuticals (Basel). %u2013 2021. %u2013 Vol. 14 (6). %u2013 Art. 560. %u2013 https://doi.org/10.3390/ph1406056013. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d., %u041c%u0430%u043b%u0438%u043d %u0414.%u0418., %u0420%u044b%u0432%u043a%u0438%u043d %u041f.%u0412., %u0421%u044b%u0447%u0435%u0432 %u0414.%u0410. %u041b%u0435%u043a%u0430%u0440%u0441%u0442%u0432%u0435%u043d%u043d%u044b%u0435 %u0432%u0437%u0430%u0438%u043c%u043e%u0434%u0435%u0439%u0441%u0442%u0432%u0438%u044f %u043f%u0440%u0435%u043f%u0430%u0440%u0430%u0442%u043e%u0432, %u043f%u0440%u0438%u043c%u0435%u043d%u044f%u0435%u043c%u044b%u0445 %u0432 %u043f%u0441%u0438%u0445%u0438%u0430%u0442%u0440%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u043f%u0440%u0430%u043a%u0442%u0438%u043a%u0435 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2019. %u2013 %u2116 S1. %u2013 %u0421. 2%u201335. %u2013 https://doi.org/10.21265/PSYPH.2019.50.4082813. Mosolov S.N., Malin D.I., Ryvkin P.V., Sychev D.A. Lekarstvennye vzaimodejstvija preparatov, primenjaemyh v psihiatricheskoj praktike // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2019. %u2013 %u2116 S1. %u2013 S. 2%u201335. %u2013 https://doi.org/10.21265/PSYPH.2019.50.4082814. Hiemke C., Bergemann N., Clement H., Conca A., Deckert J. et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. // Pharmacopsychiatry. %u2013 2018. %u2013 Vol. 51 (01/02). %u2013 Pp. 9%u201362. %u2013 https://doi.org/10.1055/s-0043-11649214. Hiemke C., Bergemann N., Clement H., Conca A., Deckert J. et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. // Pharmacopsychiatry. %u2013 2018. %u2013 Vol. 51 (01/02). %u2013 Pp. 9%u201362. %u2013 https://doi.org/10.1055/s-0043-11649215. %u041c%u0438%u0440%u043e%u0448%u043d%u0438%u0447%u0435%u043d%u043a%u043e %u0418.%u0418., %u041f%u043b%u0430%u0442%u043e%u0432%u0430 %u0410.%u0418., %u041a%u0443%u0437%u044c%u043c%u0438%u043d %u0418.%u0418., %u0418%u0432%u0430%u0449%u0435%u043d%u043a%u043e %u0414.%u0412. %u041a%u043e%u043b%u0438%u0447%u0435%u0441%u0442%u0432%u0435%u043d%u043d%u043e%u0435 %u043e%u043f%u0440%u0435%u0434%u0435%u043b%u0435%u043d%u0438%u0435 %u0444%u0435%u043d%u0430%u0437%u0435%u043f%u0430%u043c%u0430 %u0438 %u0435%u0433%u043e %u0430%u043a%u0442%u0438%u0432%u043d%u043e%u0433%u043e %u043c%u0435%u0442%u0430%u0431%u043e%u043b%u0438%u0442%u0430 %u0432 %u043f%u043b%u0430%u0437%u043c%u0435 %u043a%u0440%u043e%u0432%u0438 %u0447%u0435%u043b%u043e%u0432%u0435%u043a%u0430 %u043f%u0440%u0438 %u0440%u0430%u0437%u043b%u0438%u0447%u043d%u044b%u0445 %u043f%u0440%u043e%u0446%u0435%u0434%u0443%u0440%u0430%u0445 %u044d%u043a%u0441%u0442%u0440%u0430%u043a%u0446%u0438%u0438 // %u0420%u0430%u0437%u0440%u0430%u0431%u043e%u0442%u043a%u0430 %u0438 %u0440%u0435%u0433%u0438%u0441%u0442%u0440%u0430%u0446%u0438%u044f %u043b%u0435%u043a%u0430%u0440%u0441%u0442%u0432%u0435%u043d%u043d%u044b%u0445 %u0441%u0440%u0435%u0434%u0441%u0442%u0432. %u2013 2024. %u2013 %u2116 13 (3). %u2013 %u0421. 139%u2013147. %u2013 https://doi.org/10.33380/2305-2066-2024-13-3-160915. Miroshnichenko I.I., Platova A.I., Kuzmin I.I., Ivashchenko D.V. Kolichestvennoe opredelenie fenazepama i ego aktivnogo metabolita v plazme krovi cheloveka pri razlichnyh procedurah jekstrakcii // Razrabotka i registracija lekarstvennyh sredstv. %u2013 2024. %u2013 %u2116 13 (3). %u2013 S. 139%u2013147. %u2013 https://doi.org/10.33380/2305-2066-2024-13-3-160916. Chan B.K.C. Data analysis using R programming // Advances Exper Med Biol. %u2013 2018. %u2013 1082. %u2013 Pp. 47%u2013122. %u2013 https://doi.org/10.1007/978-3-319-93791-5_216. Chan B.K.C. Data analysis using R programming // Advances Exper Med Biol. %u2013 2018. %u2013 1082. %u2013 Pp. 47%u2013122. %u2013 https://doi.org/10.1007/978-3-319-93791-5_217. Bailey K., Richards-Waugh L., Clay D., Gebhardt M., Mahmoud H., Kraner J.C. Fatality involving the ingestion of phenazepam and poppy seed tea // J Analytical Toxicology. %u2013 2010. %u2013 Vol. 34. %u2013 Pp. 527%u2013532.17. Bailey K., Richards-Waugh L., Clay D., Gebhardt M., Mahmoud H., Kraner J.C. Fatality involving the ingestion of phenazepam and poppy seed tea // J Analytical Toxicology. %u2013 2010. %u2013 Vol. 34. %u2013 Pp. 527%u2013532.18. Walson P.D. Personalized minimal effective concentration therapy // Clinical Therapeutics. %u2013 2023. %u2013 Vol. 45 (12). %u2013 Pp. 1289%u20131292. %u2013 https://doi.org/10.1016/j.clinthera.2023.09.01518. Walson P.D. Personalized minimal effective concentration therapy // Clinical Therapeutics. %u2013 2023. %u2013 Vol. 45 (12). %u2013 Pp. 1289%u20131292. %u2013 https://doi.org/10.1016/j.clinthera.2023.09.01519. Jian J., He D., Gao S., Tao X., Dong X. Pharmacokinetics in pharmacometabolomics: Towards personalized medication // Pharmaceuticals (Basel). %u2013 2023. %u2013 Vol. 16 (11). %u2013 Art. 1568. %u2013 https://doi.org/10.3390/ph1611156819. Jian J., He D., Gao S., Tao X., Dong X. Pharmacokinetics in pharmacometabolomics: Towards personalized medication // Pharmaceuticals (Basel). %u2013 2023. %u2013 Vol. 16 (11). %u2013 Art. 1568. %u2013 https://doi.org/10.3390/ph1611156820. St%u00f8rset E., Br%u00e5ten L.S., Ingelman-Sundberg M., Johansson I., Molden E., Kringen M.K. Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo // Eur J Clin Pharmacol. %u2013 2024. %u2013 Jul 4. %u2013 https://doi.org/10.1007/s00228-024-03721-620. St%u00f8rset E., Br%u00e5ten L.S., Ingelman-Sundberg M., Johansson I., Molden E., Kringen M.K. Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo // Eur J Clin Pharmacol. %u2013 2024. %u2013 Jul 4. %u2013 https://doi.org/10.1007/s00228-024-03721-6